mylan and association for accessible medicines executives discuss the business of healthcare
Published 6 years ago • 880 plays • Length 29:29Download video MP4
Download video MP3
Similar videos
-
0:59
association for accessible medicines - your generics & biosimilars industry
-
0:33
accessible medicines for everyone - aam
-
1:44
aam ceo chip davis on the quality of generic prescription drugs
-
38:33
aam all access - managing drug shortages
-
23:07
what will it take to bring biosimilars to the market?
-
3:05
mylan ceo: epipen $608 price was 'fair'
-
2:34
mylan ceo grilled by congress over epipen price hikes
-
3:04
mylan ceo heather bresch breaks down the path pricing epipen | squawk box | cnbc
-
7:11
mylan ceo on fda-approved biosimilar, trump's drug price plan
-
1:05
biosimilars council -- leading on biosimilars for america's patients
-
22:10
aam all access - jeff watson
-
16:25
the business of medical communications: a guide to getting started in account management
-
15:01
euronews debates highlights | how can europe shape the future of biosimilar medicines?
-
2:31
health-care m&a takes center stage with mylan-pfizer, exact-genomic deals
-
7:48
welcome to the next drugs the future for biosimilars
-
0:17
aam all access promo: managing drug shortages part 1
-
0:22
aam all access promo: mary beth powers
-
0:18
aam all access promo: managing drug shortages part 2
-
18:46
aam all access mary beth powers of cmmb
-
44:44
the business of integrative medicine webcast